CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) The Science Underlying COVID-19: Implications for the Cardiovascular System Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging? Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus Initial Invasive or Conservative Strategy for Stable Coronary Disease Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

Clinical Trial2020 Dec 11;S1936-878X(20)30941-4.

JOURNAL:JACC Cardiovasc Imaging. Article Link

High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonobstructive Coronary Disease: A Randomized Study

J Henzel, C Kępka, M Kruk et al. Keywords: high-risk plaque burden; ASCVD progression; lifestyle intervention; RCT

Full Text PDF